Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: September 2019
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 4 of 4 items.
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17
Needle-free dermal filler devices used for cosmetic skin treatments are not authorized in Canada and may pose health risks
AlertInformation update | 2019-09-13
Health Canada assessing NDMA in ranitidine
AlertInformation update | 2019-09-13
Information Update - Health Canada warns of potential risk of pulmonary illness associated with vaping products
AlertInformation update | 2019-09-04